Schizophrenia Trial, Recruiting NCT06345963 Sponsor: The University of Texas Health Science Center, Houston Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT06345963
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 60 years old, of any gender
  • People who are able to read and sign a consent form agreeing to take part
  • People who have been diagnosed with a schizophrenia-spectrum disorder and who score above 10 on a specific assessment used to check their ability to give informed consent (confirm with trial site)

Who may not be able to join:

  • People who are unable to sign a consent form
  • People who have any history of seizures
  • People who have an unstable or serious medical condition that may affect how the brain works, such as a recent stroke, significant head injury, an infection or tumour in the brain, or other major brain-related conditions (confirm with trial site for specific situations)
  • People who are currently taking more than 400 mg of clozapine per day
  • People who do not pass a standard safety screening questionnaire for TMS (a type of brain stimulation used in the trial)
  • People who have had significant alcohol or drug dependence in the past 6 months, or drug misuse in the past month, not including nicotine or marijuana
  • People who have a personal or family history of blood clots, or a medical condition that increases the chance of developing blood clots
  • Women who may be pregnant, including those who have missed a period, report a possible pregnancy, or test positive on a urine pregnancy test
  • People who have had a head injury involving more than 10 minutes of unconsciousness, or who have had brain surgery
  • People who are unable to avoid using alcohol or marijuana for at least 24 hours before study sessions
  • Current students or employees working in the research lab conducting this trial
  • People who are unable to have an MRI scan due to metal implants or devices in their body (such as a pacemaker, neurostimulator, metal pins, surgical clips, or artificial joints), or who experience severe claustrophobia in an MRI scanner

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Xiaoming Du, PhD, The University of Texas Health Science Center, Houston

Phone: 713-486-2740

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 May 2024
Est. completion
1 May 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Brain microstructural integrity as indicated by white matter fractional anisotropy (FA) values as assessed by magnetic resonance imaging (MRI); Brain connectivity as indicated by resting-state functional connectivity (rsFC) values as assessed by functional MRI (fMRI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov